Allara Health review

Allara Health: a women's clinic that prescribes GLP-1s, not a GLP-1 clinic with a women's brand on it

The first thing to establish about any women's-health telehealth brand is whether it actually writes the prescription, because a great many of them treat the condition and stop short of the drug. Allara writes it. Its prescription page names semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound) and liraglutide (Saxenda), adds the once-daily Wegovy tablet and orforglipron as Foundayo, and its public intake offers GLP-1s as something a patient can say she is curious about before it has asked her date of birth. That is a service, not an explainer.

What Allara does not do is compound. The word appears on none of its pages, no in-house pharmacy is involved, and prescriptions are "electronically sent directly to your preferred local pharmacy or a mail-order pharmacy of your choice." On a roster where most of the cheap options are compounded vials from a lab the provider will not name, that is a meaningful difference in what you are buying — and it is also why the money works the way it does.

$149 a month, and the drug is not in it

Allara's pricing is refreshingly plain: $149 a month for the Complete Care Program, which is medical care plus nutrition, or $125 a month for nutrition alone. There is no first-month teaser, no prepaid-year tier, no discount that expires — three things this market does almost reflexively — and the same page carries the words "No long-term commitment." After a year of correcting headline rates that turned out to be twelve-month prepay footnotes, it is worth saying plainly that this one is what it looks like.

The catch is the sentence in the terms: the price of prescriptions is "not included in any subscription fees." Because Allara prescribes brand pens only, that unbilled half is not a modest add-on. With a pharmacy benefit that covers Wegovy or Zepbound it can be a copay, and $149 for an OBGYN, a dietitian and lab panels is then a genuinely good trade. Without coverage there is no cheap lane here at all — no compounded fallback, no flat cash rate, nothing between you and the retail counter. Our guide to what a GLP-1 costs without insurance is the right thing to read before you assume which of those two mothers you are.

One number we will not print is a GLP-1 price, because Allara does not publish one. A first read of its prescription page attributed a "starting at $77" figure to the GLP-1 card; a second fetch of the same page places that figure against hormone therapy and finds no starting price on the GLP-1 card at all. We record the disagreement rather than the number.

What the $149 actually buys

• A named clinical discipline, not a job title: "OBGYNs, WHNPs, Endocrinologists, and Registered Dietitians," all board-certified and US-licensed
• The same two people every time: one medical provider and one registered dietitian, retained across visits rather than whoever is on shift
• Real testing: extensive hormonal and metabolic panels, ordered as part of the program — though what you pay for them still depends on your plan
• A published follow-up cadence: check-ins "every 1-2 weeks or as often as recommended by your provider", which is the most specific promise on this roster
• Insurance for the visits: Aetna, Blue Cross Blue Shield, Cigna, United Healthcare and GEHA — qualified, in Allara's own words, "in some states"

The conditions list is the reason this record exists on a mothers' masthead: PCOS, insulin resistance, endometriosis, Hashimoto's, primary ovarian insufficiency, menopause, PMDD, fibroids, fertility. A mother whose weight sits downstream of any of those has spent years explaining her own endocrinology to clinicians who were treating a number. Here it is the premise. Our piece on GLP-1s and PCOS sets out how little of the evidence is actually PCOS-specific, which is precisely the conversation you would want a prescriber to be equipped for.

The cost is calendar, not money

Everything good about this program is scheduled. A 30-minute video visit with an OBGYN or nurse practitioner, a 45-minute video visit with a dietitian, then check-ins every one to two weeks. There is nothing asynchronous about it. For a mother whose week has no thirty-minute hole in it — never mind forty-five — that is a real and recurring cost, and it is the single clearest reason to choose something else. The programs on this board that ask nothing of your calendar also ask nothing about your thyroid. You are choosing which of those matters more.

Where the record gets untidy

Coverage is published as a list rather than an all-fifty claim, which is the right instinct — full medical and nutrition care in 45 states plus the District of Columbia, with a nutrition-only membership in Hawaii, Kansas, New Mexico, Rhode Island and South Carolina. Read that carefully: in those five there is no prescribing at all. Then read it twice, because Allara's how-it-works page says 43 states where its pricing page says 45. Two pages, one company, a two-state gap. The insurance list carries its own hedge — "in some states" — with no carrier-by-state map and no copay figure anywhere.

The terms do something similar with refunds. Clause 27 is exactly what you want: terminate at any time, no fee, notice 48 hours before the next billing cycle. Clause 28 offers refunds within 30 days, "at the discretion of our Clinical Operations team." The subscriptions section of the same document says fees are "final and non-refundable unless expressly stated otherwise." Binding arbitration and a class-action waiver sit underneath all of it. None of that is unusual; the internal contradiction is worth knowing about before you need to rely on one clause rather than the other.

The part it gets right that almost nobody does

The intake asks whether you are pregnant, and offers "No, but I'm trying to conceive" as its own answer, before it asks your date of birth. Then the published drug-level safety information does something rarer still: it carries the instruction to stop at least two months before a planned pregnancy, and it separates the Wegovy tablet, where breastfeeding is not recommended, from the injectables, where the instruction is to tell your provider. That distinction is wrong on a great many health sites and it is right here. It does not change the standing answer — no GLP-1 is established as safe in pregnancy or lactation, and every label advises against use — but a program that screens for it at the door and gets the labelling right afterwards has earned some trust. Read what to tell your OB before starting and take the timing decision to your own clinician regardless.

The bottom line

Allara is the strongest clinical proposition on this masthead and one of the weakest budget ones, and both facts come from the same decision: it prescribes real, FDA-approved pens through your own pharmacy and charges you for the care instead of the vial. If you have coverage worth using and a condition worth treating, very little here is better. If you are paying cash, or your week cannot carry two long appointments and a fortnightly check-in, our #1 pick, CoreAge Rx, holds one flat all-in number at every dose — compare them head to head, or see the whole field in our best GLP-1 for women ranking.